*2.4. YGS Treatment Shows Higher Survival Rate for Aβ<sup>42</sup> Flies*

Figure 3 shows the survival rate of mCD8 and Aβ42 flies under sham and YGS treatments. Both days after eclosion of mCD8 flies (as normal control) with sham and YGS treatment are longer than those of Aβ<sup>42</sup> flies with sham and YGS treatment, and days after eclosion of Aβ<sup>42</sup> flies with YGS treatment are longer than those of Aβ<sup>42</sup> flies with sham treatment. Our results reveal that YGS treatment should be able to prolong survival duration for Aβ<sup>42</sup> flies.

**Figure 3.** The survival rate of mCD8 and Aβ<sup>42</sup> flies under sham and YGS treatments. Days after eclosion of mCD8 flies (normal control) with sham (*N* = 300) and YGS treatment (*N* = 300) are longer than those of Aβ<sup>42</sup> flies with sham (*N* = 300) and YGS treatment (*N* = 300), and days after eclosion of Aβ<sup>42</sup> flies with YGS treatment are longer than those of Aβ<sup>42</sup> flies with sham treatment. In other words, YGS treatment should be able to prolong survival duration for Aβ<sup>42</sup> flies. Abbreviations: YGS, Yi-Gan-San; Aβ, amyloid-beta.
